# Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers

> **NCT00945178** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 11 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AZD1386
- **DRUG:** Placebo for AZD1386
- **DRUG:** Naproxen
- **DRUG:** Placebo for Naproxen

## Key facts

- **NCT ID:** NCT00945178
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** The study was terminated due to results in another study (NCT00878501).
- **Last updated:** 2010-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00945178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00945178, "Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00945178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*